Logo image of PRE.MI

PREDICT SPA (PRE.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:PRE - IT0005611071 - Common Stock

0.835 EUR
-0.02 (-2.34%)
Last: 12/23/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to PRE. PRE was compared to 32 industry peers in the Health Care Providers & Services industry. PRE is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. PRE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • PRE had positive earnings in the past year.
PRE.MI Yearly Net Income VS EBIT VS OCF VS FCFPRE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 500K -500K 1M -1M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.11%, PRE belongs to the top of the industry, outperforming 89.29% of the companies in the same industry.
  • The Return On Equity of PRE (16.48%) is better than 82.14% of its industry peers.
  • PRE has a better Return On Invested Capital (14.60%) than 96.43% of its industry peers.
Industry RankSector Rank
ROA 7.11%
ROE 16.48%
ROIC 14.6%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PRE.MI Yearly ROA, ROE, ROICPRE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2 4 6

1.3 Margins

  • With an excellent Profit Margin value of 5.07%, PRE belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
  • PRE has a Operating Margin of 7.76%. This is comparable to the rest of the industry: PRE outperforms 57.14% of its industry peers.
  • Looking at the Gross Margin, with a value of 20.96%, PRE is in line with its industry, outperforming 46.43% of the companies in the same industry.
Industry RankSector Rank
OM 7.76%
PM (TTM) 5.07%
GM 20.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PRE.MI Yearly Profit, Operating, Gross MarginsPRE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 5 10 15 20

More info and screens

7

2. Health

2.1 Basic Checks

  • PRE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • There is no outstanding debt for PRE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PRE.MI Yearly Shares OutstandingPRE.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 1M 2M 3M 4M 5M
PRE.MI Yearly Total Debt VS Total AssetsPRE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2M 4M 6M

2.2 Solvency

  • An Altman-Z score of 3.54 indicates that PRE is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 3.54, PRE belongs to the best of the industry, outperforming 89.29% of the companies in the same industry.
  • There is no outstanding debt for PRE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.54
ROIC/WACC1.91
WACC7.66%
PRE.MI Yearly LT Debt VS Equity VS FCFPRE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 1M -1M 2M

2.3 Liquidity

  • PRE has a Current Ratio of 1.27. This is a normal value and indicates that PRE is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.27, PRE is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
  • PRE has a Quick Ratio of 1.27. This is a bad value and indicates that PRE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • PRE's Quick ratio of 0.90 is in line compared to the rest of the industry. PRE outperforms 53.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.9
PRE.MI Yearly Current Assets VS Current LiabilitesPRE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 76.14% over the past year.
  • Looking at the last year, PRE shows a decrease in Revenue. The Revenue has decreased by -7.84% in the last year.
EPS 1Y (TTM)76.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1757.14%
Revenue 1Y (TTM)-7.84%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-46.31%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PRE.MI Yearly Revenue VS EstimatesPRE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2M 4M 6M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.92, the valuation of PRE can be described as correct.
  • Compared to the rest of the industry, the Price/Earnings ratio of PRE indicates a somewhat cheap valuation: PRE is cheaper than 75.00% of the companies listed in the same industry.
  • PRE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.47.
Industry RankSector Rank
PE 13.92
Fwd PE N/A
PRE.MI Price Earnings VS Forward Price EarningsPRE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PRE.MI Per share dataPRE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for PRE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

PREDICT SPA

BIT:PRE (12/23/2025, 7:00:00 PM)

0.835

-0.02 (-2.34%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.65M
Revenue(TTM)6.63M
Net Income(TTM)336.00K
Analysts80
Price Target1.94 (132.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.92
Fwd PE N/A
P/S 0.7
P/FCF N/A
P/OCF N/A
P/B 2.28
P/tB 2.88
EV/EBITDA N/A
EPS(TTM)0.06
EY7.19%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.19
BVpS0.37
TBVpS0.29
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.7
Profitability
Industry RankSector Rank
ROA 7.11%
ROE 16.48%
ROCE 21.65%
ROIC 14.6%
ROICexc 16.05%
ROICexgc 19.99%
OM 7.76%
PM (TTM) 5.07%
GM 20.96%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 0.9
Altman-Z 3.54
F-ScoreN/A
WACC7.66%
ROIC/WACC1.91
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1757.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.84%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-46.31%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y56.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

PREDICT SPA / PRE.MI FAQ

What is the ChartMill fundamental rating of PREDICT SPA (PRE.MI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to PRE.MI.


What is the valuation status for PRE stock?

ChartMill assigns a valuation rating of 1 / 10 to PREDICT SPA (PRE.MI). This can be considered as Overvalued.


Can you provide the profitability details for PREDICT SPA?

PREDICT SPA (PRE.MI) has a profitability rating of 4 / 10.


What is the valuation of PREDICT SPA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for PREDICT SPA (PRE.MI) is 13.92 and the Price/Book (PB) ratio is 2.28.